Ute Mercker
Direttore/Membro del Consiglio presso OMEICOS Therapeutics GmbH
Profilo
Ute Mercker is currently an Investment Director at IBB Beteiligungsgesellschaft mbH since 1997 and a Director at OMEICOS Therapeutics GmbH since 2015.
Previously, she held positions as Vice Chairman-Supervisory Board at Scienion AG, Director at Humedics GmbH, and Member-Supervisory Board at GenPat77 Pharmacogenetics AG.
Ms. Mercker holds an MBA from Freie Universität Berlin.
Posizioni attive di Ute Mercker
Società | Posizione | Inizio |
---|---|---|
IBB Beteiligungsgesellschaft mbH
IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany. | Investitore di Private Equity | 01/11/1997 |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | 01/03/2015 |
Precedenti posizioni note di Ute Mercker
Società | Posizione | Fine |
---|---|---|
GenPat77 Pharmacogenetics AG
GenPat77 Pharmacogenetics AG Miscellaneous Commercial ServicesCommercial Services GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | 30/07/2008 |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Direttore/Membro del Consiglio | - |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | - |
Formazione di Ute Mercker
Freie Universität Berlin | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
IBB Beteiligungsgesellschaft mbH
IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany. | Finance |
GenPat77 Pharmacogenetics AG
GenPat77 Pharmacogenetics AG Miscellaneous Commercial ServicesCommercial Services GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany. | Commercial Services |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Technology Services |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Health Technology |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Ute Mercker